The aim of the present research is to verify the immune status against tetanus in students and workers exposed to risk and to ascertain whether a decennial booster is necessary. Antibodies against tetanus were measured in 1433 workers and students of Padua University (Italy). The enrolment criterion was the ability to provide a booklet of vaccinations released by a public health office. The influence of age, gender, the number of vaccine doses, and the interval since the last dose was determined. Ten years after the last dose, the majority of subjects (95.0%) displayed an antibody titre above the protective level (≥0.10 IU/ml), and half of these (49.1%) had a long-term protective level (≥1.0 IU/ml). According to our data, titre depends on both the number of vaccine doses and the interval since the last dose (P<0.0001). Five vaccine doses and an interval of at least 10 years since the last dose are predictive of a long-term protective titre in absence of a booster (1.97 IU/ml). These data suggest that when primary series are completed, a decennial booster is unnecessary for up to twenty years. Furthermore, we recommend measuring the antibody level before a new booster is given to prevent problems related to overimmunization.

Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers

BORELLA VENTURINI, MATTEO;FRASSON, CLARA;PALUAN, FILIPPO;DE NUZZO, DAVIDE;DI MASI, GIACOMO;GIRALDO, MONICA;CHIARA, FEDERICA;TREVISAN, ANDREA
2017

Abstract

The aim of the present research is to verify the immune status against tetanus in students and workers exposed to risk and to ascertain whether a decennial booster is necessary. Antibodies against tetanus were measured in 1433 workers and students of Padua University (Italy). The enrolment criterion was the ability to provide a booklet of vaccinations released by a public health office. The influence of age, gender, the number of vaccine doses, and the interval since the last dose was determined. Ten years after the last dose, the majority of subjects (95.0%) displayed an antibody titre above the protective level (≥0.10 IU/ml), and half of these (49.1%) had a long-term protective level (≥1.0 IU/ml). According to our data, titre depends on both the number of vaccine doses and the interval since the last dose (P<0.0001). Five vaccine doses and an interval of at least 10 years since the last dose are predictive of a long-term protective titre in absence of a booster (1.97 IU/ml). These data suggest that when primary series are completed, a decennial booster is unnecessary for up to twenty years. Furthermore, we recommend measuring the antibody level before a new booster is given to prevent problems related to overimmunization.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3235168
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 10
social impact